Adenosine A2A receptor activation attenuates tubuloglomerular feedback responses by stimulation of endothelial nitric oxide synthase

American Journal of Physiology - Renal Physiology

Volumn 300, Issue 2, 2011, Pages

  Carlström, Mattias ^a   Wilcox, Christopher S ^a   Welch, William J ^a  

^a GEORGETOWN UNIVERSITY   (United States)

Author keywords

Afferent arterioles; Kidney; Micropuncture; Neuronal nitric oxide synthase; Renal microcirculation

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE A1 RECEPTOR; ADENOSINE A2A RECEPTOR; ADENOSINE A2A RECEPTOR AGONIST; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ISOENZYME; N(G) NITROARGININE METHYL ESTER; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; 2 (4 (2 CARBOXYETHYL)PHENETHYLAMINO) 5' N ETHYLCARBOXAMIDOADENOSINE; 2-(4-(2-CARBOXYETHYL)PHENETHYLAMINO)-5'-N-ETHYLCARBOXAMIDOADENOSINE; ADENOSINE; ADENOSINE A2 RECEPTOR AGONIST; ARGININE; DRUG DERIVATIVE; ENZYME INHIBITOR; N(G) PROPYLARGININE; N(OMEGA)-PROPYLARGININE; NOS3 PROTEIN, RAT; PHENETHYLAMINE DERIVATIVE;

ANIMAL EXPERIMENT; ARTERIOLE; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; GLOMERULUS; JUXTAGLOMERULAR APPARATUS; KIDNEY TUBULE; MALE; MICTURITION; NONHUMAN; PRIORITY JOURNAL; PUNCH BIOPSY; RAT; STATISTICAL SIGNIFICANCE; VASOCONSTRICTION; ANIMAL; DRUG EFFECT; FEEDBACK SYSTEM; METABOLISM; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ADENOSINE; ADENOSINE A2 RECEPTOR AGONISTS; ANIMALS; ARGININE; ARTERIOLES; BLOOD PRESSURE; ENZYME INHIBITORS; FEEDBACK, PHYSIOLOGICAL; KIDNEY GLOMERULUS; KIDNEY TUBULES; MALE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; PHENETHYLAMINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ADENOSINE A2A; URINATION;

EID: 79551507617     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00567.2010     Document Type: Article

References (58)

1. Al-Mashhadi RH, Skott O, Vanhoutte PM, Hansen PB. Activation of A(2) adenosine receptors dilates cortical efferent arterioles in mouse. Kidney Int 75: 793-799, 2009.
2. Araujo M, Welch WJ. Cyclooxygenase 2 inhibition suppresses tubuloglomerular feedback: roles of thromboxane receptors and nitric oxide. Am J Physiol Renal Physiol 296: F790-F794, 2009.
3. Brown R, Ollerstam A, Johansson B, Skott O, Gebre-Medhin S, Fredholm B, Persson AE. Abolished tubuloglomerular feedback and increased plasma renin in adenosine A1 receptor-deficient mice. Am J Physiol Regul Integr Comp Physiol 281: R1362-R1367, 2001.
4. Brown R, Ollerstam A, Persson AE. Neuronal nitric oxide synthase inhibition sensitizes the tubuloglomerular feedback mechanism after volume expansion. Kidney Int 65: 1349-1356, 2004.
5. Carlstrom M, Lai EY, Ma Z, Patzak A, Brown RD, Persson AE. Role of NOX2 in the regulation of afferent arteriole responsiveness. Am J Physiol Regul Integr Comp Physiol 296: R72-R79, 2009.
6. 2 receptors modulate tubuloglomerular feedback. Am J Physiol Renal Physiol 299: F412-F417, 2010.
7. Feng MG, Navar LG. Adenosine A2 receptor activation attenuates afferent arteriolar autoregulation during adenosine receptor saturation in rats. Hypertension 50: 744-749, 2007.
8. Franco M, Bell PD, Navar LG. Effect of adenosine A1 analogue on tubuloglomerular feedback mechanism. Am J Physiol Renal Fluid Electrolyte Physiol 257: F231-F236, 1989.
9. Fu Y, Zhang R, Lu D, Liu H, Chandrashekar K, Juncos LA, Liu R. NOX2 is the primary source of angiotensin II-induced superoxide in the macula densa. Am J Physiol Regul Integr Comp Physiol 298: R707-R712, 2010.
10. Furfine ES, Harmon MF, Paith JE, Garvey EP. Selective inhibition of constitutive nitric oxide synthase by L-NG-nitroarginine. Biochemistry 32: 8512-8517, 1993.
11. Garvey EP, Tuttle JV, Covington K, Merrill BM, Wood ER, Baylis SA, Charles IG. Purification and characterization of the constitutive nitric oxide synthase from human placenta. Arch Biochem Biophys 311: 235-241, 1994.
12. Hansen PB, Hashimoto S, Oppermann M, Huang Y, Briggs JP, Schnermann J. Vasoconstrictor and vasodilator effects of adenosine in the mouse kidney due to preferential activation of A1 or A2 adenosine receptors. J Pharmacol Exp Ther 315: 1150-1157, 2005.
13. Inscho EW. ATP, P2 receptors and the renal microcirculation. Purinergic Signal 5: 447-460, 2009.
14. Inscho EW, Cook AK, Imig JD, Vial C, Evans RJ. Physiological role for P2X1 receptors in renal microvascular autoregulatory behavior. J Clin Invest 112: 1895-1905, 2003.
15. Ito S, Arima S, Ren YL, Juncos LA, Carretero OA. Endothelium-derived relaxing factor/nitric oxide modulates angiotensin II action in the isolated microperfused rabbit afferent but not efferent arteriole. J Clin Invest 91: 2012-2019, 1993.
16. Ito S, Ren Y. Evidence for the role of nitric oxide in macula densa control of glomerular hemodynamics. J Clin Invest 92: 1093-1098, 1993.
17. Jackson EK, Zhu C, Tofovic SP. Expression of adenosine receptors in the preglomerular microcirculation. Am J Physiol Renal Physiol 283: F41-F51, 2002.
18. Kakoki M, Zou AP, Mattson DL. The influence of nitric oxide synthase 1 on blood flow and interstitial nitric oxide in the kidney. Am J Physiol Regul Integr Comp Physiol 281: R91-R97, 2001.
19. Kawabata M, Ogawa T, Takabatake T. Control of rat glomerular microcirculation by juxtaglomerular adenosine A1 receptors. Kidney Int Suppl 67: S228-S230, 1998.
20. Klotz KN. Adenosine receptors and their ligands. Naunyn Schmiedebergs Arch Pharmacol 362: 382-391, 2000.
21. Kohagura K, Endo Y, Ito O, Arima S, Omata K, Ito S. Endogenous nitric oxide and epoxyeicosatrienoic acids modulate angiotensin II-induced constriction in the rabbit afferent arteriole. Acta Physiol Scand 168: 107-112, 2000.
22. Lai EY, Patzak A, Steege A, Mrowka R, Brown R, Spielmann N, Persson PB, Fredholm BB, Persson AE. Contribution of adenosine receptors in the control of arteriolar tone and adenosine-angiotensin II interaction. Kidney Int 70: 690-698, 2006.
23. Li JM, Fenton RA, Cutler BS, Dobson JG Jr. Adenosine enhances nitric oxide production by vascular endothelial cells. Am J Physiol Cell Physiol 269: C519-C523, 1995.
24. Liu R, Ren Y, Garvin JL, Carretero OA. Superoxide enhances tubuloglomerular feedback by constricting the afferent arteriole. Kidney Int 66: 268-274, 2004.
25. Moore PK, al-Swayeh OA, Chong NW, Evans RA, Gibson A. L-NG-nitro arginine (L-NOARG), a novel, L-arginine-reversible inhibitor of endothelium-dependent vasodilatation in vitro. Br J Pharmacol 99: 408-412, 1990.
26. Mozaffari MS, Abebe W, Warren BK. Renal adenosine A3 receptors in the rat: assessment of functional role. Can J Physiol Pharmacol 78: 428-432, 2000.
27. Nekooeian AA, Tabrizchi R. Effects of CGS 21680, a selective A2A adenosine receptor agonist, on cardiac output and vascular resistance in acute heart failure in the anaesthetized rat. Br J Pharmacol 123: 1666-1672, 1998.
28. Nekooeian AA, Tabrizchi R. Haemodynamic effects of a selective adenosine A2A receptor agonist, CGS 21680, in chronic heart failure in anaesthetized rats. Br J Pharmacol 125: 651-658, 1998.
29. Nishiyama A, Inscho EW, Navar LG. Interactions of adenosine A1 and A2a receptors on renal microvascular reactivity. Am J Physiol Renal Physiol 280: F406-F414, 2001.
30. Osswald H, Hermes HH, Nabakowski G. Role of adenosine in signal transmission of tubuloglomerular feedback. Kidney Int Suppl 12: S136-S142, 1982.
31. Patzak A, Mrowka R, Storch E, Hocher B, Persson PB. Interaction of angiotensin II and nitric oxide in isolated perfused afferent arterioles of mice. J Am Soc Nephrol 12: 1122-1127, 2001.
32. Patzak A, Steege A, Lai EY, Brinkmann JO, Kupsch E, Spielmann N, Gericke A, Skalweit A, Stegbauer J, Persson PB, Seeliger E. Angiotensin II response in afferent arterioles of mice lacking either the endothelial or neuronal isoform of nitric oxide synthase. Am J Physiol Regul Integr Comp Physiol 294: R429-R437, 2008.
33. Persson AE, Brown R, Liu R, Ollerstam A. Nitric oxide modulates and adenosine mediates the tubuloglomerular feedback mechanism. Acta Physiol Scand 176: 91-94, 2002.
34. Phillis JW. The selective adenosine A2 receptor agonist, CGS 21680, is a potent depressant of cerebral cortical neuronal activity. Brain Res 509: 328-330, 1990.
35. Plato CF, Stoos BA, Wang D, Garvin JL. Endogenous nitric oxide inhibits chloride transport in the thick ascending limb. Am J Physiol Renal Physiol 276: F159-F163, 1999.
36. Ray CJ, Marshall JM. The cellular mechanisms by which adenosine evokes release of nitric oxide from rat aortic endothelium. J Physiol 570: 85-96, 2006.
37. Ren Y, Arima S, Carretero OA, Ito S. Possible role of adenosine in macula densa control of glomerular hemodynamics. Kidney Int 61: 169-176, 2002.
38. Ren Y, Garvin JL, Carretero OA. Efferent arteriole tubuloglomerular feedback in the renal nephron. Kidney Int 59: 222-229, 2001.
39. Ren YL, Garvin JL, Ito S, Carretero OA. Role of neuronal nitric oxide synthase in the macula densa. Kidney Int 60: 1676-1683, 2001.
40. - and NO. Am J Physiol Renal Physiol 279: F302-F308, 2000.
41. Schnermann J. Effect of adenosine analogs on tubuloglomerular feedback responses. Am J Physiol Renal Fluid Electrolyte Physiol 255: F33-F42, 1988.
42. Schnermann J, Briggs JP. Tubuloglomerular feedback: mechanistic insights from gene-manipulated mice. Kidney Int 74: 418-426, 2008.
43. Schnermann J, Levine DZ. Paracrine factors in tubuloglomerular feedback: adenosine, ATP, and nitric oxide. Annu Rev Physiol 65: 501-529, 2003.
44. Schnermann J, Persson AE, Agerup B. Tubuloglomerular feedback. Nonlinear relation between glomerular hydrostatic pressure and loop of henle perfusion rate. J Clin Invest 52: 862-869, 1973.
45. Schnermann J, Weihprecht H, Briggs JP. Inhibition of tubuloglomerular feedback during adenosine1 receptor blockade. Am J Physiol Renal Fluid Electrolyte Physiol 258: F553-F561, 1990.
46. Sun D, Samuelson LC, Yang T, Huang Y, Paliege A, Saunders T, Briggs J, Schnermann J. Mediation of tubuloglomerular feedback by adenosine: evidence from mice lacking adenosine 1 receptors. Proc Natl Acad Sci USA 98: 9983-9988, 2001.
47. Teng B, Ledent C, Mustafa SJ. Up-regulation of A 2B adenosine receptor in A 2A adenosine receptor knockout mouse coronary artery. J Mol Cell Cardiol 44: 905-914, 2008.
48. Thorup C, Erik A, Persson G. Macula densa derived nitric oxide in regulation of glomerular capillary pressure. Kidney Int 49: 430-436, 1996.
49. Thorup C, Persson AE. Inhibition of locally produced nitric oxide resets tubuloglomerular feedback mechanism. Am J Physiol Renal Fluid Electrolyte Physiol 267: F606-F611, 1994.
50. Trottier G, Triggle CR, O'Neill SK, Loutzenhiser R. Cyclic GMP-dependent and cyclic GMP-independent actions of nitric oxide on the renal afferent arteriole. Br J Pharmacol 125: 563-569, 1998.
51. Vallon V, Muhlbauer B, Osswald H. Adenosine and kidney function. Physiol Rev 86: 901-940, 2006.
52. Vallon V, Traynor T, Barajas L, Huang YG, Briggs JP, Schnermann J. Feedback control of glomerular vascular tone in neuronal nitric oxide synthase knockout mice. J Am Soc Nephrol 12: 1599-1606, 2001.
53. Vitzthum H, Weiss B, Bachleitner W, Kramer BK, Kurtz A. Gene expression of adenosine receptors along the nephron. Kidney Int 65: 1180-1190, 2004.
54. Wang H, Carretero OA, Garvin JL. Nitric oxide produced by THAL nitric oxide synthase inhibits TGF. Hypertension 39: 662-666, 2002.
55. Welch WJ, Tojo A, Lee JU, Kang DG, Schnackenberg CG, Wilcox CS. Nitric oxide synthase in the JGA of the SHR: expression and role in tubuloglomerular feedback. Am J Physiol Renal Physiol 277: F130-F138, 1999.
56. Welch WJ, Tojo A, Wilcox CS. Roles of NO and oxygen radicals in tubuloglomerular feedback in SHR. Am J Physiol Renal Physiol 278: F769-F776, 2000.
57. Wilcox CS, Welch WJ, Murad F, Gross SS, Taylor G, Levi R, Schmidt HH. Nitric oxide synthase in macula densa regulates glomerular capillary pressure. Proc Natl Acad Sci USA 89: 11993-11997, 1992.
58. Zhang HQ, Fast W, Marletta MA, Martasek P, Silverman RB. Potent and selective inhibition of neuronal nitric oxide synthase by N omegapropyl-L- arginine. J Med Chem 40: 3869-3870, 1997.